Has Ben Shofty, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,516 in general payments to Ben Shofty, MD across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ben Shofty, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ben Shofty, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ben Shofty, MD

Neurological Surgery · Houston, TXNPI 1699304022

Payments from drug & device makers

$14,516in general payments, 2019–2025

Across 104 payments — averaging $139.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$6K
Boston Scientific$3K
Medtronic$2K
Neuropace, Inc.$1K
Monteris Medical Corporation$1K
DIXI Medical USA Corp$927
plus $663 from 2 others

What the payments were for

Speaking & faculty fees$4,06328%
Travel & lodging$3,11321%
Food & beverage$7,34051%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	28	$5,888
Boston Scientific	29	$2,715
Medtronic	24	$1,861
Neuropace, Inc.	9	$1,280
Monteris Medical Corporation	4	$1,181
DIXI Medical USA Corp	2	$927
Brainlab, Inc.	7	$633
Johnson & Johnson	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,516 in reported general payments places this provider in the 70th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$54,692

Medicare patients

Services billed

193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Houston

Daniel CurryHouston$3M
Homero AnchondoHouston$799K
Claudio TatsuiHouston$777K
Arthur DayHouston$746K
Andrew RoeserHouston$660K
Peng ChenHouston$550K
Daniel YoshorHouston$519K
Paul HolmanHouston$516K
Nitin TandonHouston$510K
Nelson MossHouston$501K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →